The enduring pneumococcus: unfinished business and opportunities for the future.
Austrian
R
R
Department of Molecular and Cellular Engineering, University of Pennsylvania, School of Medicine, Philadelphia 19104-6088, USA.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000502:physiology*
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines